Text Size

Effectiveness of Group Based Schema Therapy in the Treatment of Personality Disorders

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00247234
First received: October 31, 2005
Last updated: March 8, 2012
Last verified: March 2012
History of Changes
  Purpose

This study intends to compare the effectiveness of schema therapy with standard psychiatric outpatient care for patients with borderline or avoidant personality disorder.


Condition Intervention Phase
Personality Disorder, Borderline
Avoidant Personality Disorder
 Behavioral: Schema Therapy
Behavioral: standard care
 Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Effectiveness of Group Based Schema Therapy in the Treatment of Borderline Personality Disorder and Avoidant Personality Disorder

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • quality of life [ Time Frame: 5 years ] [ Designated as safety issue: No ]
    Self-report measures

  • depression [ Time Frame: 5 years ] [ Designated as safety issue: No ]
    Self-report measures

  • anxiety [ Time Frame: 5 years ] [ Designated as safety issue: No ]
    Self-report measures

  • suicidal ideation [ Time Frame: 5 years ] [ Designated as safety issue: No ]
    Self-report measures


Secondary Outcome Measures:
  • Use of psychotropic medication [ Time Frame: 5 years ] [ Designated as safety issue: No ]

Estimated Enrollment: 96
Study Start Date: September 2004
Estimated Study Completion Date: January 2015
Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: schema therapy Behavioral: Schema Therapy
group based schema therapy
Active Comparator: standard care
standard psychiatric out-patient care
 Behavioral: standard care
standard psychiatric out-patient care

  Eligibility

Ages Eligible for Study:   20 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Avoidant or Borderline personality disorders

Exclusion Criteria:

  • Do not speak Scandinavian languages
  • Antisocial personality disorder
  • Narcissistic personality disorder
  • Affective bipolar disorder I
  • Schizophrenia
  • Mental impairment/organic brain disorder
  • Substance dependence
  • Planned pregnancy
  • Serious somatic illness
  • Anorexia Nervosa
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00247234

Locations
Norway
St. Olavs Hospital
Trondheim, Norway, 7030
Sponsors and Collaborators
Norwegian University of Science and Technology
Investigators
Study Chair: Are Holen, M.D., Ph.D. Department of Neuroscience, NTNU - Faculty of Medicine, MTFS, NO-7489 Trondheim, Norway
  More Information

No publications provided

Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00247234     History of Changes
Other Study ID Numbers: ursula.falkmer+AEA-stolav.no
Study First Received: October 31, 2005
Last Updated: March 8, 2012
Health Authority: Norway:National Committee for Medical and Health Research Ethics

Additional relevant MeSH terms:
Personality Disorders
Borderline Personality Disorder
Mental Disorders

ClinicalTrials.gov processed this record on May 19, 2013